Citi Downgrades Medivation (MDVN) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Citi Downgrades Medivation (MDVN) to Neutral

Brean Capital Downgrades Medivation (MDVN) to Hold

August 22, 2016 1:01 PM EDT

Brean Capital downgraded Medivation (NASDAQ: MDVN) from Buy to Hold.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Wedbush Downgrades Medivation (MDVN) to Neutral

August 22, 2016 1:00 PM EDT

Wedbush downgraded Medivation (NASDAQ: MDVN) from Outperform to Neutral.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Pfizer (PFE) to Acquire Medivation (MDVN) in $14B Deal

August 22, 2016 6:45 AM EDT

Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (Nasdaq: MDVN) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion. The Boards of Directors of both companies have unanimously approved the merger, which is expected to be immediately accretive to Pfizers Adjusted Diluted EPS upon closing, approximately $0.05 accretive in the first full year after close with... More